Infection Control and Antibiotic Use in Hospital
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: closed (30 October 2022) | Viewed by 10330
Special Issue Editors
Interests: antimicrobial therapy; multidrug-resistant bacteria; immunocompromised patients; human parasitic diseases; antibiotic stewardship
Special Issues, Collections and Topics in MDPI journals
Interests: hospital acquired infections; MDR infections; antimicrobial stewardship
Interests: multidrug-resistant bacteria; immunocompromised; carbapenem-resistant Enterobacterales; intensive care unit; critically ill patients; liver cirrhosis; solid organ transplantation; haematologic malignancies
Interests: antimicrobial resistance; carbapenem resistance; antimicrobial stewardship
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The reduction of healthcare-associated infections (HAI) remains one of the main objectives of health policy by implementing actions aimed at the prevention and control of infections and targeted antimicrobial management programs. The COVID-19 epidemic has highlighted an increased risk of hospital infections in particular settings such as intensive care settings and at the same time better management of antimicrobials where antimicrobial stewardship programs were already underway and well-structured. HAI are of particular interest due to the antimicrobial resistance related to them, often the cause of serious clinical course and increased mortality. The spread of carbapenem-resistant strains represented and represents a worldwide emergency. Of particular interest are the infections caused by Acinetobacter baumannii, Clostridioides (Clostridium) difficile, Stenotrophomonas maltophilia, Pseudomonas aeruginosa and by Enterobacteriales carbapenem-resistant. Resistance to colistin has recently been detected in several countries, making it difficult to treat infections caused by these bacteria. Of equal importance are infections sustained by methicillin-resistant staphylococci and by vancomycin-resistant enterococci. Particularly emerging are candidemia and invasive candidiasis. Healthcare-associated infections also represent a real problem due to the high costs associated with them: some estimates assume the overall annual direct costs to hospitals in the US ranging from $ 28 to $ 45 billion. Such infections require appropriate use of antibiotics and well-structured infection control and antibiotic stewardship programs. The introduction of new antimicrobials opens up new therapeutic strategies to treat infections caused by microorganisms with a broad spectrum of resistance. In this special issue of “Antibiotics”, we intend to collect original research articles, short communications or review articles concerning infection control programs in several settings and the appropriate use of antimicrobials with particular reference to new molecules with action on multidrug-resistant bacteria and antimicrobial stewardship.
Dr. Rosario Cultrera
Prof. Dr. Mario Tumbarello
Dr. Michele Bartoletti
Dr. Daniele Roberto Giacobbe
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.